Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 58,500 shares at $91.54 ($5.4M) on 2024-04-04, disclosed to the SEC on 2024-04-04.
Scheduled sale ($5.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.54 | 9,820 | $899K | 16.6% |
| 2 | $91.54 | 9,820 | $899K | 16.6% |
| 3 | $92.70 | 16,618 | $1.5M | 28.5% |
| 4 | $92.70 | 16,618 | $1.5M | 28.5% |
| 5 | $93.72 | 2,712 | $254K | 4.7% |
| 6 | $93.72 | 2,712 |
| $254K |
| 4.7% |
| 7 | $94.19 | 200 | $19K | 0.3% |
| Total | $92.41 avg | 58,500 | $5.4M | 100% |
| Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |
| EW | SELL | 2023-12-13 | $3.6M | — | Filing → |